Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An analytical framework for immunization programs in Canada.

L J Erickson1, P De Wals, L Farand

  • 1Département d'administration de la santé, Université de Montréal, Montréal, Canada. lonny.erickson@aetmis.gouv.qc.ca

Vaccine
|March 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of social norms in the context of reducing sugar-sweetened beverages consumption.

Public health·2022
Same author

Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch.

Vaccine·2019
Same author

Middle ear abnormalities at age 5 years in relation with early onset otitis media and number of episodes, in the Inuit population of Nunavik, Quebec, Canada.

International journal of circumpolar health·2019
Same author

Prevalence of middle ear abnormalities from otitis media in relation with pneumococcal vaccine use in the Inuit population of Nunavik, province of Quebec, Canada.

Vaccine·2018
Same author

Hospitalisation for lower respiratory tract infection in children in the province of Quebec, Canada, before and during the pneumococcal conjugate vaccine era.

Epidemiology and infection·2017
Same author

The Quebec experience in promoting healthy lifestyles and preventing obesity: how can we do better?

Obesity reviews : an official journal of the International Association for the Study of Obesity·2017
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

A new analytical framework helps analyze and compare immunization programs in Canada. It aids decision-making for vaccine choices amid limited funding and differing provincial needs.

Area of Science:

  • Public Health
  • Health Policy
  • Vaccinology

Background:

  • Increasing availability of new vaccines in Canada presents challenges for provincial and territorial immunization programs.
  • Limited funding necessitates careful selection of health interventions and immunization strategies.
  • Divergence in program choices among Canadian jurisdictions highlights the need for structured decision support.

Purpose of the Study:

  • To present a comprehensive analytical framework for the analysis and comparison of potential immunization programs.
  • To provide a structured approach for evaluating vaccine interventions considering multiple criteria.
  • To support evidence-based decision-making in Canadian immunization policy.

Main Methods:

  • Development of an analytical framework with 58 criteria across 13 categories.

Related Experiment Videos

  • Categories include disease burden, vaccine characteristics, cost-effectiveness, equity, and ethical considerations.
  • Framework applied in various contexts, including expert consultations and priority setting.

    • Main Results:

    • The framework provides a systematic approach to evaluating immunization programs.
    • It has been used to structure expert discussions and identify areas of consensus and divergence.
    • The framework facilitates priority setting for vaccine implementation.

    Conclusions:

    • The developed analytical framework offers a robust tool for immunization program analysis.
    • It can assist Canadian jurisdictions in navigating complex decisions regarding vaccine adoption.
    • The framework is adaptable for educating health professionals and the public on immunization.